EP4247371
EZH2-hindrunarmeðferðir til meðhöndlunar á andrógen-viðtaka-stökkbreyttum krabbameinum í blöðruhálskirtli
:
EP einkaleyfi í gildi á Íslandi:
18.11.2021:
1.1.2025:
21827282.1
:
19.3.2025:
15.4.2025
:
17.11.2041:
17.11.2025
:
EZH2 INHIBITION THERAPIES FOR THE TREATMENT OF ANDROGEN RECEPTOR MUTATED PROSTATE CANCERS
18.11.2021
1.1.2025
19.3.2025
15.4.2025
17.11.2025
:
Constellation Pharmaceuticals, Inc.:
470 Atlantic Avenue, Suite 1401, Boston, MA 02210, US
:
BRADLEY, William, D.:
Winchester, MA 01890, US
:
CUI, Jike:
Belmont, MA 02478, US
:
SUN, Kaiming:
Belmont, MA 02478, US
:
TROJER, Patrick:
Reading, MA 01867, US
:
WANG, Jing:
Lexington, MA 20420, US
:
WU, Rentian:
Winchester, MA 01890, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
202063115165 P:
18.11.2020:
US
:
US2021059847:
18.11.2021
:
A61K 31/4433, A61K 31/4166, A61K 45/06, A61P 35/00, A61P 35/04